Altamira Therapeutics Ltd. Shareholders' Equity
Altamira Therapeutics Ltd. (CYTOF) had Shareholders' Equity of CHF 16.77 million as of 2020-12-31, per its 20-F filed 2021-03-31.
Discontinued › Balance Sheet › Equity
us-gaap:StockholdersEquity · last filed 2021-03-31
- 2020-12-31: Stockholders' Equity Attributable to Parent 16.77M CHF.
- 2019-12-31: Stockholders' Equity Attributable to Parent 6.04M CHF.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2020-12-31 | 16.77M CHF 20-F · filed 2021-03-31 |
| 2019-12-31 | 6.04M CHF 20-F · filed 2021-03-31 |